Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Clinical Oral Implants Research|June 15, 2011
Lack of influence of the Schneiderian membrane in forming new bone apical to implants simultaneously installed with sinus floor elevation: an experimental study in monkeysAlessandro Scala, Daniele Botticelli, Rafael Silveira Faeda, et al.Current Cancer Drug Targets|January 8, 2025
The Clinical Role of Hypoxia Inducible Factor (HIF) Inhibition in Renal Cancer: A Focus on BelzutifanDaniela Arduini, Chiara Ciccarese, Alessandro Strusi, et al.Frontiers in Oncology|January 19, 2024
Multimodality treatment in recurrent/metastatic squamous cell carcinoma of head and neck: current therapy, challenges, and future perspectivesSergio Pannunzio, Armando Di Bello, Denis Occhipinti, et al.Expert Review of Anticancer Therapy|June 24, 2024
2024 ASCO genitourinary cancers symposium: a focus on renal cell carcinomaViria Beccia, Daniela Arduini, Roberto Iacovelli, et al.Oral and Maxillofacial Surgery|June 15, 2020
Sequential healing of the elevated sinus floor with different size of antrostomy: a histomorphometric study in rabbitsAlessandro Scala, Jose Viña-Almunia, Carmen Carda, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 8, 2025
Complete Response to Lorlatinib in Lung Adenocarcinoma With EML4-ALK Fusion Variant (E6;A18): Case Report and Literature ReviewAntonio Vitale, Elisa De Paolis, Jacopo Russo, et al.Cancer|March 29, 2024
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced non-small cell lung cancerEmanuele Vita, Federico Monaca, Domenico Milardi, et al.Frontiers in Oncology|July 30, 2025
Enhanced response to dabrafenib plus trametinib in a patient with BRAF V600E lung cancer harboring an RNF43 variant of unknown significance: a case reportEttore D'Argento, Antonio Vitale, Jacopo Russo, et al.Frontiers in Immunology|November 21, 2022
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapyAndrea Botticelli, Giulia Pomati, Alessio Cirillo, et al.Journal of Clinical Medicine|February 13, 2026
Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World StudyAntonello Veccia, Ettore D'Argento, Floriana Morgillo, et al.Pageof 3